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Addition of L-valine (50 to 200 mM) to glucose minimal medium had no effect on the growth of wild-type
Corynebacterium glutamicum ATCC 13032 but inhibited the growth of the derived valine production strain VAL1
[13032 ilvA panBC(pJC1ilvBNCD)] in a concentration-dependent manner. In order to explore this strain-
specific valine effect, genomewide expression profiling was performed using DNA microarrays, which showed
that valine caused an increased ilvBN mRNA level in VAL1 but not in the wild type. This unexpected result was
confirmed by an increased cellular level of the ilvB protein product, i.e., the large subunit of acetohydroxyacid
synthase (AHAS), and by an increased AHAS activity of valine-treated VAL1 cells. The conclusion that valine
caused the limitation of another branched-chain amino acid was confirmed by showing that high concentra-
tions of L-isoleucine could relieve the valine effect on VAL1 whereas L-leucine had the same effect as valine. The
valine-caused isoleucine limitation was supported by the finding that the inhibitory valine effect was linked to
the ilvA deletion that results in isoleucine auxotrophy. Taken together, these results implied that the valine
effect is caused by competition for uptake of isoleucine by the carrier BrnQ, which transports all branched-
chained amino acids. Indeed, valine inhibition could also be relieved by supplementing VAL1 with the dipeptide
isoleucyl-isoleucine, which is taken up by a dipeptide transport system rather than by BrnQ. Interestingly,
addition of external valine stimulated valine production by VAL1. This effect is most probably due to a reduced
carbon usage for biomass production and to the increased expression of ilvBN, indicating that AHAS activity
may still be a limiting factor for valine production in the VAL1 strain.
Corynebacterium glutamicum was isolated as an L-glutamate-
excreting bacterium (1) and is used today for the large-scale
biotechnological production of two amino acids, i.e., L-gluta-
mate (800,000 tons per year), a flavor enhancer, and L-lysine
(400,000 tons per year), which is mainly used as a feed additive
(17). In contrast to glutamate, lysine can be produced only by
an appropriate mutant strain of C. glutamicum, e.g., MH20-
22B (50), which accumulates 230 mM L-lysine in the culture
medium. The use of C. glutamicum for lysine production is
particularly advantageous, since it is a “GRAS” (generally re-
garded as safe) organism, and therefore, downstream process-
ing of lysine does not require separation from the biomass.
For a number of reasons, C. glutamicum is very well suited
for the production of additional amino acids. (i) The regulation
of biosynthetic pathways is often less complex in C. glutamicum
than in many other bacteria. For example, C. glutamicum pos-
sesses only one acetohydroxyacid synthase (AHAS) (28), while
Escherichia coli contains three differently regulated isoenzymes
(3, 56). (ii) Central carbon metabolism, anaplerotic reactions,
and several amino acid biosynthesis pathways, as well as many
transport processes, have been studied in great detail in C.
glutamicum (45). (iii) The genome sequence is known, and
effective tools for genetic manipulation are available.
By metabolic engineering, C. glutamicum strains that pro-
duce L-valine have been created (41). This branched-chain
amino acid is essential for vertebrates, and its production is of
commercial interest because of its use as a feed additive, for
infusion solutions, and as a precursor for the chemical synthe-
sis of herbicides (17, 34). Currently, 500 tons of L-valine is
produced per year by fermentation or extraction from acidic
hydrolysates of proteins (17). As shown in Fig. 1, valine is
synthesized from two molecules of pyruvate in a pathway in-
volving four reactions which are catalyzed by AHAS (the ilvBN
gene product), isomeroreductase (the ilvC gene product), di-
hydroxyacid dehydratase (the ilvD gene product), and transam-
inase B (the ilvE gene product). As in other organisms, the
same enzymes also catalyze the synthesis of L-isoleucine from
pyruvate and 2-ketobutyrate. The latter is formed from L-
threonine by threonine dehydratase (the ilvA gene product).
AHAS is the key enzyme of branched-chain amino acid syn-
thesis. This enzyme is feedback inhibited by valine, leucine,
and isoleucine, but even in the presence of all three amino
acids, the activity is inhibited maximally to 50% (16, 19). In
E. coli, the effect of valine on its three AHAS isoenzymes has
been described (54). Valine causes feedback inhibition of
AHAS I, encoded by ilvBN, and AHAS III, encoded by ilvIH
(13), and their small regulatory subunits, IlvN and IlvH, were
shown to be necessary for valine sensitivity (6, 7, 20). In con-
trast, AHAS II, encoded by ilvGM, is resistant to valine (4, 13,
24, 54). In the presence of valine, the lack of ilvGM expression
in E. coli K-12 causes a growth defect due to 2-ketobutyrate
toxicity and leucine and isoleucine limitation (13, 24, 31, 54,
59). Valine-resistant mutants of E. coli K-12 showed restored
ilvGM expression (31). In E. coli, valine regulates the expres-
sion of ilvBN, as well as ilvGMEDA, by an attenuation mech-
anism (14, 21, 25, 32, 54), whereas ilvIH expression is con-
trolled by the leucine-responsive protein Lrp (43, 54, 55). In C.
glutamicum, the synthesis of AHAS is regulated as well. Ex-
pression of ilvBN is altered about twofold in response to the
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branched-chain amino acid concentration via an attenuation
mechanism (38). In contrast to a direct amino acid deficiency,
a valine, leucine, and pantothenate shortage due to ketobu-
tyrate addition led to10-fold-increased AHAS activity, prob-
ably caused by an additional as-yet-unknown control (16, 38).
The C. glutamicum valine production strain 13032 ilvA
panBC(pJC1ilvBNCD) (called VAL1 hereafter), derived
from the wild type by metabolic engineering, excretes up to 90
mM L-valine (41). This was made possible by a number of
defined genetic alterations. (i) The valine biosynthesis genes
ilvB, ilvN, ilvC, and ilvD were overexpressed from a plasmid.
(ii) The chromosomal ilvA gene was deleted in order to avoid
the formation of isoleucine as a major by-product. In addition,
cultivation of the strain under isoleucine limitation could in-
crease ilvBN expression by the attenuation mechanism (38).
(iii) The panBC genes encoding two steps in the D-pantothe-
nate synthesis pathway were deleted. Pantothenate is a con-
stituent of coenzyme A (CoA) (27) and thus is required for the
oxidative decarboxylation of pyruvate to acetyl-CoA by the
pyruvate dehydrogenase complex. Cultivation under pantothe-
nate limitation will limit this reaction and thereby increase the
availability of the valine precursor pyruvate.
Within a project aiming to improve valine production by
further metabolic engineering of the VAL1 strain, the question
arose as to what effects the presence of valine itself would have
on growth and valine production. This question was triggered
by the observation that addition of 30 mM L-valine or L-iso-
leucine to the culture medium significantly reduced the growth
rate of the lysine producer C. glutamicum MH20-22B (18). It
was speculated that the hydrophobicity of these branched-
chain amino acids was somehow responsible for the deleterious
effect, because the hydrophilic amino acids L-alanine and L-
lysine caused no inhibition. In addition, mischarging of tRNA
has been discussed as an alternative explanation (18). The
inhibitory effect could also be responsible for the generally
lower levels of production by C. glutamicum of nonpolar amino
acids like valine compared to polar amino acids like lysine (34).
Since the mechanism of growth inhibition of C. glutamicum
MH20-22B by valine and isoleucine remained unexplained, we
decided to study the influence of valine on wild-type C. glu-
tamicum ATCC 13032 and on the valine production strain
VAL1 by combining growth studies with transcriptome and
proteome analyses.
MATERIALS AND METHODS
Bacterial strains, plasmids, media, and growth conditions. The bacterial
strains and plasmids used in this work are listed in Table 1. For the first precul-
ture, 5 ml of CGIII medium (37) was inoculated from a fresh Luria-Bertani (47)
agar plate and incubated overnight at 30°C and 170 rpm. The cells were har-
vested and used to inoculate 60 ml of CGXII medium (28) containing 0.03 g of
protocatechuic acid/liter and 0.2 M glucose. This second preculture was grown
overnight at 30°C and 120 rpm in a 500-ml baffled shake flask. The main culture
was inoculated with cells from the second preculture and grown under the same
conditions. Strains with the panBC deletion were supplemented with 3 M
sodium D-pantothenate, and strains with the ilvA deletion were supplemented
with 3.4 mM L-isoleucine. Strains carrying pJC1-derived plasmids were cultivated
in the presence of 50 g of kanamycin/ml. When desired, branched-chain amino
acids were added to CGXII medium before the pH was titrated to 7.0, and then
the medium was autoclaved.
For transcriptome analysis, proteome analysis, and determination of AHAS
activity, the CGXII preculture contained the same supplements as the main
culture to ensure full adaptation. Main cultures were harvested in the exponen-
tial growth phase. Altogether, the bacteria were cultivated for at least 10 gen-
erations under equivalent conditions.
Generation of C. glutamicum DNA microarrays. DNA microarrays based on
the PCR products of C. glutamicum genes were used for global gene expression
analysis. The genes were amplified in 96-well plates with genomic DNA of C.
glutamicum ATCC 13032 as a template and gene-specific primers purchased
from degussa (Frankfurt, Germany). The sizes and quantities of the PCR prod-
ucts were checked by gel electrophoresis. Then, the PCR products were precip-
itated with isopropanol, resuspended in 3 SSC (20 SSC is 3 M NaCl and 0.3
M sodium citrate, pH 7.0), and transferred to 384-well plates as described
previously (57, 61; http://cmgm.stanford.edu/pbrown/mguide/index.html). The
PCR products were printed onto poly-L-lysine-coated glass slides using an ar-
raying robot (http://cmgm.stanford.edu/pbrown/mguide/index.html). The DNA
microarrays were rehydrated in a humidity chamber containing 1 SSC, UV
cross-linked (650 J), and blocked in 230 ml of methylpyrrolidinone containing
15 ml of 1 M boric acid (titrated to pH 8.0 with sodium hydroxide) and 4.4 g
of succinic anhydride (57, 61; http://cmgm.stanford.edu/pbrown/mguide/index
.html). Depending on the series, the DNA microarrays contained PCR products
for up to 3,530 of 3,567 predicted C. glutamicum open reading frames. Most
FIG. 1. Biosynthetic pathways of L-valine, L-isoleucine, L-leucine,
and D-pantothenate in C. glutamicum. The solid arrows indicate reac-
tions catalyzed by the indicated enzymes, and the dotted arrows indi-
cate multistep pathways. Relevant gene names are given in parentheses.
TABLE 1. Strains and plasmids
Strain or plasmid Relevant characteristic(s)a Reference
C. glutamicum strains
ATCC 13032 Wild type 1
13032 ilvA ilvA deletion mutant 44
13032 panBC panBC deletion mutant 41
13032 ilvA panBC ilvA and panBC deletion mutant 41
13032 ilvA panBC(pJC1ilvBNCD) (VAL1) ilvA and panBC deletion mutant with plasmid pJC1ilvBNCD 41
Plasmids
pJC1 E. coli-C. glutamicum shuttle vector; Kanr oriVE.c. oriVC.g. 11
pJC1ilvBNCD pJC1 with restriction fragments encompassing ilvBNC and ilvD with their native promoters 44
a Subscripts: E.c., E. coli; C.g.; C. glutamicum.
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genes were represented by a single spot, but 506 genes were represented by two
spots. Up to 100 spots of C. glutamicum genomic DNA were present as a quality
control and for normalization. As negative controls,  DNA, E. coli genomic
DNA, and the E. coli aceK gene were included.
Total RNA preparation and cDNA synthesis. Aliquots (25 ml) of exponen-
tially growing C. glutamicum cultures (optical density at 600 nm [OD600], be-
tween 3 and 5) were added to 25 g of crushed ice precooled to 20°C and
immediately harvested by centrifugation (5 min; 3,500  g; 4°C) as previously
described for E. coli (57). The cells were resuspended in 350 l of RNeasy RLT
buffer (Qiagen, Hilden, Germany) and mechanically disrupted by 30 s of bead
beating with 0.5 g of 0.1-mm-diameter zirconium-silica beads (Roth, Karlsruhe,
Germany) using a Silamat S5 (Vivadent, Ellwangen, Germany). After centrifu-
gation (2 min; 14,500  g), the supernatant was processed using the RNeasy
system (Qiagen) with DNase on-column treatment according to the manufac-
turer’s instructions for RNA extraction. The quantity and quality of the extracted
total RNA were determined by UV spectroscopy (at 260, 280, and 230 nm) and
denaturing formaldehyde agarose gel electrophoresis (47).
Identical amounts (20 to 25 g) of total RNA were used for random hexamer-
primed synthesis of fluorescently labeled cDNA by reverse transcription with
Superscript II (GibcoBRL-Life Technologies, Gaithersburg, Md.) using the flu-
orescent nucleotide analogue FluoroLink Cy3-dUTP (green) or Cy5-dUTP (red)
(Amersham Pharmacia, Little Chalfont, United Kingdom) as described before
(30, 57). The labeled cDNA probes were purified and concentrated using Mi-
crocon YM-30 filter units (Millipore, Bedford, Mass.) (30; http://cmgm.stanford
.edu/pbrown/mguide/index.html).
DNA microarray hybridization and washing. Combined Cy5- and Cy3-labeled
cDNA probes containing 1.2 g of poly(A) (Sigma, Taufkirchen, Germany)/l as
a competitor, 30 mM HEPES, and 0.3% sodium dodecyl sulfate (SDS) in 3
SSC, were hybridized to the arrays for 5 to 16 h at 65°C. After hybridization, the
arrays were washed in 1 SSC containing 0.03% SDS and finally in 0.05 SSC.
The DNA microarrays were dried by brief centrifugation (5 min; 45  g). For
detailed protocols, see reference 30 and http://cmgm.stanford.edu/pbrown/
mguide/index.html.
Data normalization and gene expression analysis. Immediately after stringent
washing of the arrays, fluorescence intensities at 635 and 532 nm were acquired
using a GenePix 4000 laser scanner (Axon Inc., Union City, Calif.) and processed
as TIFF images. Raw fluorescence data were analyzed quantitatively using
GenePix version 3.0 software (Axon Inc.). Data were normalized to the average
ratio of C. glutamicum genomic DNA. The normalized ratio of the median
(GenePix) was taken to reflect the relative RNA abundance for spots whose
green or red fluorescence signal was at least threefold above the fluorescence
background. When both fluorescence signals were less than threefold above
background, the signals were considered too weak to be analyzed quantitatively.
For statistical analysis (2, 42), P values from independent replicate experiments
were calculated based on Student’s t test using log-transformed gene ratios and
genomic DNA ratios which were normalized to zero (33). Only genes showing
significantly changed RNA levels (P values of0.05) were considered for further
analysis. Analysis of gene expression data was performed by selecting genes
showing at least twofold-increased or -decreased average RNA levels. All genes
belonging to a putative operon were listed if at least one gene of the operon
showed significant expression changes.
Proteome analysis. Proteome analysis of the soluble protein fraction was
performed by two-dimensional (2-D) gel electrophoresis essentially as described
previously (48). Cells were cultivated as described above and harvested at an
OD600 of 3 to 5 by centrifugation (5 min; 3,500  g; 4°C). After being washed in
TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA), the cells were resuspended
in either 1 or 10 ml of TE buffer containing Complete protease inhibitor (Roche
Diagnostics, Mannheim, Germany), 100 g of RNase A, and 25 g of DNase I,
depending on whether disruption was performed by bead beating (1 ml of cell
suspension was added to 1 g of zirconium-silica beads and subjected to four
cycles [30 s] of bead beating) or by passage through a French pressure cell (10 ml
of cell suspension was passed five times through a French pressure cell [SLM
AMINCO Spectronic Instruments, Rochester, N.Y.] at 172 MPa). Intact cells
and cell debris were removed by centrifugation (20 min; 27,000 g; 4°C), and the
soluble protein fraction was separated from the membrane protein fraction by
ultracentrifugation (1 h; 150,000  g; 4°C). Protein concentrations were deter-
mined using the BC assay kit (Pierce Chemical Company, Rockford, Ill.), and
300 g of protein was precipitated with acetone. After solubilization, isoelectric
focusing was performed using an IPGphor electrophoresis unit (Amersham
Pharmacia) and 18-cm-long Immobiline DryStrips (Amersham Pharmacia) with
a pH range of 4 to 7 or 4.5 to 5.5. After being focused, the Immobiline DryStrips
were equilibrated and 2-D separation was performed using a Multiphor II elec-
trophoresis unit and Excel SDS gradient gels (12 to 14%; Amersham Pharma-
cia). The gels were fixed, Coomassie stained, destained, and dried as described
previously (48).
The gels were scanned with a JX-330 scanner (Sharp, Tokyo, Japan), and the
images were analyzed using ProteomeWeaver 2-D gel analysis software version
1.1.3 (Definiens Imaging GmbH, Munich, Germany). Spots of interest were
excised and digested with trypsin, and the peptide masses were determined by
matrix-assisted laser desorption ionization–time of flight mass spectrometry as
described previously (48). Peptide mass lists were used to search a tryptic digest
database of 3,746 C. glutamicum proteins provided by degussa.
Determination of amino acid concentrations by HPLC. L-Valine concentra-
tions were determined by automatic precolumn derivatization with ortho-phthal-
dialdehyde (35) and reversed-phase high-performance liquid chromatography
(HPLC) (HP1100 series; Hewlett-Packard, Waldbronn, Germany) with fluori-
metric detection (excitation at 230 nm; emission at 450 nm). Hypersil ODS 5-m
columns were used (precolumn, 40 by 4 mm; column, 120 by 4 mm; Chromatog-
raphie Service GmbH, Langerwehe, Germany). The buffer gradient consisted of
0.1 M sodium acetate, pH 7.2 (with 0.03% sodium azide), as the polar phase and
methanol as the nonpolar phase. Quantification was performed with L-aspara-
gine as an internal standard and by comparison of the sample peaks with an
external standard.
Determination of AHAS activity. Cells (50 ml) were harvested at an OD600 of
3 to 5 by centrifugation, washed with 50 ml of 100 mM potassium phosphate
buffer (pH 7.5), and suspended in 1 ml of 50 mM potassium phosphate buffer
(pH 7.5) containing 26% (vol/vol) glycerol. The cells were disrupted by sonifi-
cation with a microtip-equipped Branson Sonifier W-250 (Branson-Emerson,
Danbury, Conn.) for 10 min on ice (intensity, 20%; pulse length, 20%). Cell
debris and intact cells were separated from the cell extract by centrifugation (1 h;
14,500  g; 4°C). The enzyme assay was performed as described previously (16)
for 15 min at 30°C. Acetolactate formed from pyruvate was decarboxylated to
acetoin and detected by the colorimetric method of Westerfeld (58), which is
based on a reaction between acetoin and the guanidino group of creatine in the
presence of 	-naphthol and alkali. The absorbance at 530 nm was compared with
an acetoin standard. Protein concentrations were determined using the biuret
method (22). Specific AHAS activities are given as mU per milligram (nano-
moles of product formed per minute and milligram of protein).
Determination of ornithine carbamoyltransferase activity. Cultivation and
crude extract preparation were performed as described for the AHAS activity
measurement. The reaction mixture contained cell extract, 15 mM L-ornithine,
and 10 mM lithium carbamoylphosphate in potassium phosphate buffer (100
mM; pH 7.5). The enzyme assay was performed for 15 min at 30°C and stopped
by addition of HCl to a concentration of 0.2 M. The L-citrulline formed during
the reaction was detected by reversed-phase HPLC with an L-citrulline standard
as described for the determination of amino acid concentrations.
RESULTS
Growth of wild-type C. glutamicum and the VAL1 strain in
the presence of valine. Since the presence of 30 mM valine
inhibited the growth of the lysine producer C. glutamicum
MH20-22B (18), we were interested in examining the effects on
the growth of the C. glutamicum wild-type strain ATCC 13032
and the valine production strain VAL1. Cells were cultivated in
CGXII minimal medium with 0.2 M glucose and different
valine concentrations, and the growth rates were determined.
The medium for strain VAL1 was supplemented with 3 M
sodium D-pantothenate and 3.4 mM L-isoleucine. As shown in
Fig. 2, L-valine at concentrations up to 200 mM had no effect
on the growth rate of the wild type. In contrast, the VAL1
strain derived from this wild type showed decreasing growth
rates at increasing L-valine concentrations. Half-maximal inhi-
bition was found at a concentration of 250 mM L-valine (data
not shown). These results indicate that the effect of external
L-valine on the growth of C. glutamicum is strain specific. In the
context of these studies, it was also shown that wild type C.
glutamicum is unable to use L-valine as a sole carbon or a sole
nitrogen source (data not shown). This clearly indicates that C.
glutamicum lacks one or several enzyme activities required for
L-valine degradation.
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Influence of L-valine on global gene expression in wild type
C. glutamicum and the VAL1 strain. In order to find the cause
of the different effects of valine on growth of the wild type and
the VAL1 strain, its influence on global gene expression was
studied by transcriptome analysis. In the case of the wild type,
parallel cultures were grown in CGXII glucose minimal me-
dium either with or without 50, 100, or 300 mM L-valine. The
cells were kept in the exponential growth phase by repeated
dilution and harvested for RNA extraction after at least 10
generations. Relative RNA levels were determined by hybrid-
ization to DNA microarrays representing up to 3,530 different
open reading frames (ORFs) of C. glutamicum ATCC 13032
(see Materials and Methods). Table 2 lists statistically signifi-
cant gene expression changes (P value,0.05) of 23 ORFs with
at least twofold-decreased RNA levels and 16 genes with at
least twofold-increased RNA levels (in all cases, the RNA
levels represent the ratio with valine/without valine). Addition-
ally, genes that showed changes of less than twofold but that
formed an operon with one of the 39 genes that had at least
twofold-altered mRNA levels were included.
In the case of the VAL1 strain, parallel cultures were grown
in CGXII glucose minimal medium either without L-valine
(growth rate, 0.35 h1) or with 40 mM L-valine (growth rate,
0.29 h1) and used for RNA isolation and global gene expres-
sion analysis as described for the wild type. The use of 40 mM
valine was a compromise, because at that concentration the
effect of valine on the growth of VAL1 was already clearly
detectable but presumably not so strong that all gene expres-
sion changes were due to the reduced growth rate. In this
context, it has to be mentioned that the VAL1 strain is capable
of producing 90 mM L-valine by itself. However, due to the
dilution steps, there was 5 mM valine produced by VAL1 in
the medium at the time of RNA isolation. As summarized in
Table 3, 11 and 10 ORFs showed significantly changed RNA
levels (P  0.05) that were at least twofold decreased or in-
creased, respectively, after growth in the presence of valine.
Table 3 also includes those genes whose RNA levels changed
less than twofold but which presumably are cotranscribed with
one of the 21 genes showing at least twofold changes.
A comparison of the gene expression changes upon valine
addition in the wild type and the VAL1 strain identified com-
mon as well as strain-specific expression changes. Three genes
showed increased expression in the presence of valine, i.e.,
leuD, ileS, and its adjacent ORF (Tables 2 and 3). The leuD
gene encodes the small subunit of isopropylmalate dehy-
dratase, an enzyme involved in the biosynthesis of L-leucine
from 2-oxoisovalerate (39). The levels of RNA of leuC (ORF
2737; NCgl1262), encoding the large subunit of this enzyme,
were also increased in both strains but showed P values of

0.05. The ileS gene encodes isoleucyl tRNA synthetase, i.e.,
the enzyme that charges isoleucine tRNA.
Expression of several genes or operons, e.g., that of the
prpD2B2C2 operon, which is essential for growth on propi-
onate (10) and encodes enzymes involved in the methylcitrate
cycle, i.e., 2-methylcitrate synthase (prpC), 2-methylcitrate de-
hydratase (prpD), and 2-methylisocitrate lyase (prpB), was in-
creased in the presence of valine only in the wild type (Tables
2 and 3). Expression of the homologous prpD1B1C1 operon,
which is not essential for growth on propionate (10), was also
increased. Similarly, increased expression was found for the
putative narKGHJI operon that encodes a nitrate-nitrite trans-
port protein and the four subunits of nitrate reductase (narG,
with a ratio of 2.0 and a P value of 0.07) and for nearly all genes
involved in arginine biosynthesis (argC, argB, argD, argF, argG,
argH, and argR) (8, 9, 46). The increased RNA level of the argF
gene during growth in the presence of valine correlated with
increased activities of ornithine carbamoyltransferase (the argF
gene product). Wild-type cells grown in the presence or ab-
sence of valine had ornithine carbamoyltransferase activities of
210 and 95 mU/mg of protein, respectively. In the VAL1 strain,
the ornithine carbamoyltransferase activities were 145 and 120
mU/mg of protein in the presence or absence of valine, respec-
tively.
Expression of the putative oppABCD operon encoding an
oligopeptide ABC transport system was significantly increased
only in strain VAL1 (Tables 2 and 3). Finally, it was obvious
that the levels of mRNA of ilvBN, which encodes AHAS, were
increased in the presence of valine only in the VAL1 strain but
decreased or almost unaltered in the wild type (Tables 2 and
3).
Influence of L-valine on the protein profile of wild-type C.
glutamicum and the VAL1 strain. The influence of valine in the
growth medium on protein abundances in the wild type and the
VAL1 strain was examined using 2-D gels. The strains were
cultivated in CGXII glucose minimal medium with or without
300 mM L-valine in the case of the wild type and with or
without 40 mM L-valine in the case of the VAL1 strain. After
growth for at least 10 generations, the cells were harvested in
the exponential phase, and crude extracts were prepared. For
each of the four different conditions, three independent culti-
vations were performed and used for protein profiling. For
each of the 12 samples, 2-D gel electrophoresis was carried out
both in a pH range of 4 to 7 and in a range of 4.5 to 5.5. The
Coomassie-stained gels were analyzed quantitatively using
FIG. 2. Effect of L-valine in the culture medium on growth rates
() of wild-type C. glutamicum, ATCC 13032 (E), and the valine
production strain, VAL1 (). The average growth rates and standard
deviations of at least two independent cultivations are given.
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TABLE 2. ORFs showing altered relative mRNA levels in response to L-valine in the wild-type C. glutamicum ATCC 13032
ORF NCBIa Annotationb Genec
Relative mRNA level / valined
50 100a 100b 300a 300b Average
237 NCgl2749 Similarity to probable membrane protein SCQ11.10c (Streptomyces coelicolor) 0.5 0.6 0.3 0.5
585 NCgl0190 Weak similarity to putative two-component system histidine kinase SCE25.03c
(S. coelicolor)
0.5 0.5 0.5
860 NCgl0385 Hypothetical protein 0.5 0.7 0.5 0.5
1495 NCgl0891 Similarity to hypothetical protein Rv1128c (Mycobacterium tuberculosis) 0.6 0.5 0.5
1606 NCgl0986 Strong similarity to sodium-dependent proline transporter SLC6A12
(Rattus norvegicus)
0.6 0.5 0.6 0.5
1623 NCgl1004 Strong similarity to morphine 6-dehydrogenase mor A (Pseudomonas putida) 0.5 0.5 0.5
1906 NCgl2919 Similarity to hypothetical protein SCC54.19 (S. coelicolor) 0.4 0.5 0.4
1953 NCgl1770 Weak similarity to UMP synthase and OMP decarboxylase ump
(Naegleria gruberi)
0.4 0.5 0.5
2136 NCgl1952 Weak similarity to zoocin A endopeptidase (Streptococcus zooepidemicus) 0.5 0.6 0.5
2552 NCgl1405 Similarity to cell division ATP-binding protein ftsE (E. coli [putative
frameshift])
0.5 0.5 0.7 0.5
2792 NCgl1223 Acetolactate synthase small-chain ilvN (C. glutamicum) ilvN 0.4 0.4 0.3 0.8 0.7 0.5
2827 (2778481–2778807) Questionable ORF 0.4 0.4 0.6 0.8 0.5
3312 NCgl0018 Similarity to 27-kDa outer membrane protein (Coxiella burnetii) 0.5 0.6 0.5
3384 NCgl1669 Similarity to putative primase (Lactococcus bacteriophage phi31) 0.5 0.5 0.5
3396e NCgl1678 Weak similarity to hypothetical protein yciE (serovar Typhimurium) 0.4 0.4 0.4
3397e NCgl1679 Weak similarity to hypothetical protein (C. glutamicum) 0.6 0.7 0.6
3398e NCgl1680 Weak similarity to class A beta-lactamase precursor tla-I (E. coli
plasmid RZA9)
0.3 0.4 0.3
3431 NCgl2953 Strong similarity to D-xylose proton symporter xylT (Lactobacillus brevis) 0.4 0.3 0.3
3443 NCgl2960 Weak similarity to pyrroline-5-carboxylate reductase proC (E. coli) 0.5 0.5 0.5
3481 NCgl2433 Strong similarity to ATP-dependent DNA helicase dinG (E. coli) 0.6 0.5 0.5
3501e NCgl2417 Hypothetical protein 0.4 0.4 0.4
3503e NCgl2415 Strong similarity to RNase PH rph (E. coli) 0.8 0.8 0.8
3514 NCgl2407 Hypothetical protein 0.5 0.4 0.4
3549 NCgl0482 Strong similarity to ferric enterobactin ABC-type transport system
ATP-binding protein fepC (E coli)
0.4 0.3 0.3
66065 NCgl2320 Ferredoxin subunits of nitrite reductase and ring-hydroxylating
dioxygenases (C. glutamicum)
0.4 0.4 0.4
675 NCgl0254 Branched-chain amino acid exporter brnF (C. glutamicum) brnF 1.6 2.6 1.7 2.4 2.1
676 NCgl0254 Branched-chain amino acid exporter brnF (C. glutamicum) brnF 1.5 1.5 0.9 1.5 1.4
830 NCgl0359 Succinate dehydrogenase C or D sdhCD (C. glutamicum) sdhCD 1.7 1.1 1.0 2.3 4.2 2.1
1160e NCgl0627; NCgl0628 Methylaconitase prpD2 (C. glutamicum) prpD2 6.4 9.5 7.4 3.5 4.6 6.3
1161e NCgl0629 Methylisocitrate lyase prpB2 (C. glutamicum) prpB2 4.1 8.8 5.7 3.9 3.7 5.2
1162e NCgl0630 Methyl citrate synthase prpC2 (C. glutamicum) prpC2 4.0 6.7 7.5 4.6 4.2 5.4
1204e NCgl0664 Methylaconitase prpD1 (C. glutamicum) prpD1 1.4 1.9 1.4 1.1 1.1 1.4
1205e NCgl0665 Methylisocitrate lyase prpB1 (C. glutamicum) prpB1 1.1 1.7 1.5 1.4 1.4
1206e NCgl0666 Methyl citrate synthase prpC1 (C. glutamicum) prpC1 4.3 4.0 4.1 2.2 4.0 3.7
1451 NCgl0856 Glycine betaine transporter betP (C. glutamicum [putative frameshift]) betP 1.6 1.6 1.5 2.0 3.9 2.1
1783e NCgl1139 Strong similarity to nitrate reductase gamma chain narI (Bacillus subtilis) 2.2 2.2 2.2
1784e NCgl1140 Strong similarity to nitrate reductase delta chain narJ (B. subtilis) 1.0 1.0 1.0
1785e NCgl1141 Strong similarity to nitrate reductase beta chain narH (B. subtilis) 1.6 1.1 1.1 3.0 4.6 2.3
1787e NCgl1143 Strong similarity to nitrite extrusion protein narK2 (Thermus thermophilus
[putative frameshift])
1.2 1.2 1.1 1.6 2.5 1.5
1788e NCgl1143 Strong similarity to nitrite extrusion protein narK (E. coli [putative
frameshift])
1.5 1.2 1.2 2.4 2.0 1.7
2280a NCgl2086 Strong similarity to isoleucine-tRNA ligase ileS 1.9 1.4 1.4 3.1 2.6 2.1
2281a (2274263–2274442) Hypothetical protein 1.4 1.5 1.2 1.6 2.7 1.7
2622e NCgl1347 Argininosuccinate lyase argH (C. glutamicum) argH 1.2 1.5 1.1 1.1 1.8 1.3
2623e NCgl1346 Argininosuccinate synthase argG (C. glutamicum) argG 1.4 1.5 1.3 2.3 1.6 1.6
2624e NCgl1345 Arginine repressor argR (C. glutamicum) argR 1.4 1.8 1.7 3.8 1.4 2.0
2625e NCgl1344 Ornithine carbamoyltransferase argF (C. glutamicum) argF 2.1 2.4 2.4 3.5 2.0 2.5
2626e NCgl1343 Acelylornithine aminotransferase argD (C. glutamicum) argD 1.4 1.8 1.5 2.1 2.1 1.8
2627e NCgl1342 Acetylglutamate kinase argB (C. glutamicum) argB 1.7 1.9 1.9 2.4 1.4 1.9
2628e NCgl1341 Glutamate N-acetyltransferase argJ (C. glutamicum) argJ 1.3 1.4 1.3 1.9 1.5
2629e NCgl1340 N-Acetyl-gamma-glutamyl-phosphate reductase argC (C. glutamicum) argC 2.0 2.2 1.6 2.7 2.5 2.2
2736 NCgl1263 3-Isopropylmalate dehydratase small-chain leuD (C. glutamicum) leuD 2.2 1.6 1.6 5.1 3.9 2.9
2850 NCgl2504 Weak similarity to hypothetical protein (C. glutamicum) 1.8 2.1 2.0
66055 NCgl2319 Protocatechuate 3,4-dioxygenase beta subunit (C. glutamicum) 2.1 2.5 2.3
a Numbers for the corresponding ORFs of the the National Center for Biotechnology information (NCBI) revised C. glutamicum genome published by (http:
//www.ncbi.nlm.nih.gov/egi-bin/Entrez/framik?dbgenome&gi232). If no corresponding ORF exists, the position is given in parentheses.
b Most similar gene in public databases.
c Only characterized C. glutamicum genes are given.
d Relative mRNA levels with and without valine addition; and the average mRNA level from all experiments. Only ORFs with P values of  0.05 in Student’s t test
are listed; in addition to ORFs showing twofold changes of RNA levels, all ORFs of putative operons are shown. Replicate experiments are indicated by letters behind
the valine millimolar concentration.
e ORF belonging to putative operon.
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ProteomeWeaver software. Tables 4 and 5 summarize those
proteins that showed at least twofold changes in abundance
due to the presence of valine. Because of higher standard
deviations observed between protein spot intensities in com-
parison to the DNA microarray results, the criterion for sig-
nificant changes was set to a P value of 0.1 in Student’s t test
(in comparison to a P value of 0.05 for the relative RNA
levels).
In the wild type (Table 4), 11 proteins showed decreased
abundance in response to the presence of valine. However,
none of the corresponding genes displayed altered relative
RNA levels (all corresponding spots could be evaluated and
showed ratios of 1). Thus, the decrease in protein concen-
tration should be due to regulation at the level of translation or
protein stability rather than to transcriptional regulation.
Three proteins showed increased abundance in response to
valine, which in all cases correlated with increased RNA levels.
The 2-methylcitrate dehydratase PrpD2 had an eightfold-in-
creased level (mRNA level, sixfold), the arginine repressor
ArgR had a fivefold-increased level (mRNA level, twofold),
and N-acetylglutamate semialdehyde dehydrogenase, ArgC,
had a fourfold-increased level (mRNA level, twofold).
In the VAL1 strain, two proteins showed reduced abun-
dance in response to valine, one of which was the thiamine
diphosphate-dependent pyruvate dehydrogenase (EC 1.2.4.1;
component E1), which is encoded by aceE and is part of the
pyruvate dehydrogenase complex (Table 5). The correspond-
ing genes showed unaltered RNA levels under the same con-
ditions (data not shown). Three proteins displayed increased
levels in response to valine, i.e., the translation elongation
factor EF-G (twofold increase); PurH (phosphoribosylami-
noimidazolecarboxamide formyltransferase-IMP cyclohydro-
lase), a bifunctional enzyme involved in purine biosynthesis
(fourfold increase); and IlvB, the large subunit of AHAS.
Whereas the genes encoding EF-G and PurH showed no
changes in the RNA level in response to valine, the ilvB mRNA
level was increased twofold in the presence of valine (Table 3).
Remarkably, eight different spots were identified as IlvB, all
having quite similar masses of 64 to 67 kDa but pIs ranging
from 4.7 to 5.4. This could be explained by successive deg-
TABLE 3. ORFs showing altered relative mRNA levels in response to L-valine in the valine production strain VAL1a
ORF NCBI Annotation Gene
Relative mRNA level
/ valine
40a 40b 40c 40d 40e Average
638 NCgl0232 Similarity to ABC transporter strW (Streptomyces glaucescens) 0.4 0.5 0.4
732b NCgl0296 Strong similarity to hypothetical protein Rv3658c (Mycobacterium
tuberculosis)
0.5 0.6 0.5 0.5
733b NCgl0298 Strong similarity to hypothetical protein Rv3657c (M. tuberculosis) 0.6 0.8 0.6 0.7
910 NCgl0415 Hypothetical protein 0.4 0.5 0.4
1035 NCgl0528 Weak similarity to pyruvate, water dikinase ppsA (E. coli) 0.4 0.4 0.4
1155 NCgl0626 questionable ORF 0.5 0.5 0.5
1156 NCgl0626 Carbon starvation protein A cstA (C. glutamicum) 0.8 0.5 0.7 0.6
1935b NCgl2942 Strong similarity to xenobiotic reductase A (Pseudomonas putida
[putative frameshift])
0.6 0.7 0.7 0.5 0.6
1936b NCgl2942 Strong similarity to xenobiotic reductase B (P. putida [putative frameshift]) 0.3 0.9 0.4 0.5 0.5
2400 NCgl1464 Strong similarity to transposase (Pseudomonas syringae) 0.5 0.7 0.4 0.5 0.5
2789 (1341778–1341957) Hypothetical protein 0.6 0.5 0.5
3032 (2631147–2631479) Hypothetical protein 0.5 0.5 0.5
3211 (2371029–2371466) Questionable ORF 0.5 0.9 0.3 0.3 0.5
3543 NCgl0381 Similarity to hypothetical protein SCC75A. 17c (Streptomyces coelicolor) 0.5 0.4 0.5
1362 NCgl0785 Similarity to hypothetical protein Rv0867c (M. tuberculosis) 1.8 2.1 5.5 1.6 2.7
1497 NCgl0892 Strong similarity to peptide chain release factor prfC (E. coli) 1.4 1.3 1.7 3.3 2.2 2.0
2092b NCgl1915 Similarity to oligopeptide-binding protein oppA (E. coli [putative frameshift]) 1.2 1.5 2.2 1.9 2.0 1.8
2093b NCgl1915 Similarity to oligopeptide-binding protein oppA (E. coli [putative frameshift]) 0.9 1.9 2.5 4.1 1.9 2.3
2094b NCgl1916 Strong similarity to oligopeptide transport system permease protein oppB
(Bacillus subtilis)
1.1 1.5 2.0 2.2 1.7 1.7
2095b NCgl1917 Strong similarity to oligopeptide ABC transporter (permease) oppC
(B. subtilis)
0.9 1.9 2.3 2.7 1.6 1.9
2096b NCgl1918 Similarity to oligopeptide transport ATP-binding protein oppD (B. subtilis) 1.1 1.4 1.8 1.7 1.3 1.5
2280b NCgl2086 Strong similarity to isoleucine-tRNA ligase ileS 2.5 1.9 2.8 1.9 2.4 2.3
2281b (2274263–2274442) Hypothetical protein 1.1 2.0 4.1 1.8 2.3
2425 NCgl1482 Aconitase acn (C. glutamicum) acn 4.0 2.3 1.8 1.5 1.9 2.3
2453b NCgl1502 Strong similarity to hypothetical protein Rv1462 (M. tuberculosis
[putative frameshift])
2.0 1.6 2.2 1.4 1.4 1.7
2455b NCgl1503 Strong similarity to conserved hypothetical protein SCC22.07c
(S. coelicolor)
1.3 1.7 3.5 1.6 2.0
2456b NCgl1504 Strong similarity to putative transcriptional regulator Rv1460
(M. tuberculosis)
2.0 1.3 1.2 1.0 1.2 1.4
2736 NCgl1263 3-Isopropylmalate dehydratase small-chain leuD (C. glutamicum) leuD 2.9 2.3 1.4 1.4 2.0
2790b NCgl1224 Ketol-acid reductoisomerase ilvC (C. glutamicum) ilvC 1.2 1.2 1.7 1.3
2791b (1340543–1340725) Hypothetical protein 1.6 1.5 1.4 1.0 1.6 1.4
2792b NCgl1223 Acetolactate synthase small-chain ilvN (C. glutamicum) ilvN 2.4 2.3 2.9 2.6 2.4 2.5
2793b NCgl1222 Acetolactate synthase large-chain ilvB (C. glutamicum) ilvB 1.8 2.1 2.0 2.5 2.1
a Abbreviations, conditions, and statistical analysis are described in footnote to Table 2.
b ORF belonging to putative operon.
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radation of the C terminus (http://www.expasy.org/tools/pi
_tool.html). The 30 C-terminal amino acids include 10 aspar-
tate and glutamate residues, and their successive degradation
would cause predicted shifts in pI from 4.82 to 5.14 and in mass
from 66.8 to 63.8 kDa.
Influence of valine on the AHAS activity of the wild type and
the VAL1 strain. The transcriptome studies revealed different
effects of valine on the ilvBN mRNA levels in the wild type and
the VAL1 strain, which at least partly correlated with the
protein levels. Since AHAS is the key enzyme of branched-
chain amino acid biosynthesis, it was important to complement
the mRNA and protein data by activity measurements. As
shown in Table 6, the AHAS activity in the wild type (20
mU/mg of protein) was not influenced by the presence of 300
mM valine in the growth medium. In the VAL1 strain, the
activity of cells grown in the absence of externally added valine
was 200 mU/mg of protein. This 10-fold increase compared to
the wild type is most probably due to increased expression of
ilvBN from the plasmid pJC1ilvBNCD. After growth in the
presence of 40 mM added valine, the AHAS activity rose to
700 mU/mg. This 3.5-fold increase in AHAS activity correlated
well with the 2.5-fold-increased RNA levels of the ilvBN genes
and with the increased IlvB protein level.
Influence of branched-chain amino acids on growth and
AHAS activity of the VAL1 strain. To examine whether the
inhibitory effect of valine on growth and the stimulatory effect
on AHAS activity of strain VAL1 are specific for valine and to
gain more insight into the mechanism causing these effects, the
influences of L-leucine and L-isoleucine and of all possible
combinations of branched-chain amino acids (40 mM each) on
growth and on AHAS activity were tested. The doubling times
of the different cultures are shown in Fig. 3A, and the corre-
sponding AHAS activities are shown in Fig. 3B. It is obvious
that not only valine but also leucine inhibited the growth of
VAL1 and stimulated AHAS activity. From the effects of the
different combinations, it is very clear that only the mixture of
valine and leucine had qualitatively the same effect as valine or
leucine alone, whereas all combinations that included 40 mM
TABLE 4. Proteins showing altered abundances on 2-D gels in response to L-valine in the wild-type C. glutamicum ATCC 13032
ORF NCBIa Annotationb Genea
Intensity
Val Val Ratio
16 NCgl2582 Identical to L-2.3-butanediol dehydrogenase (Brevibacterium saccharolyticum) 1.9 0.8 0.4
68 NCgl2621 Strong similarity to GroEL2 protein (Mycobacterium tuberculosis) 0.5 0.2 0.4
486 NCgl0099 Strong similarity to aryl-alcohol dehydrogenase (NADP) (Phanerochaete chrysosporium) 0.5 0.2 0.4
978 NCgl0469 Strong similarity to 50S ribosomal protein L12 (Streptomyces coelicolor) 20.0 7.5 0.4
1167 NCgl0634 Isocitrate dehydrogenase icd (C. glutamicum) icd 1.0 0.4 0.4
1211 NCgl0670 accBC; acyl coenzyme A carboxylase (C. glutamicum) accBC 0.6 0.2 0.3
1315 NCgl0754 Strong similarity to hypothetical protein Rv2606c (M. tuberculosis) 1.1 0.4 0.4
2071 NCgl1900 Strong similarity to guanosine pentaphosphate synthetase gpsI (Streptomyces antibioticus) 0.3 0.1 0.4
2149 NCgl1961 Similarity to thiamin-phosphate pyrophosphorylase thiC (Bacillus subtilis) 0.5 0.1 0.3
2470 NCgl1512 Transketolase tkt (C. glutamicum) tkt 0.5 0.2 0.4
3065 NCgl2268 Similarity to phosphoglycerate mutase SCC123.14c (S. coelicolor) 0.8 0.3 0.3
1160 NCgl0627; NCgl0628 Methylaconitase prpD2 (C. glutamicum) prpD2 0.4 3.4 7.9
2624 NCgl1345 Arginine repressor argR (C. glutamicum) argR 0.1 0.4 4.8
2629 NCgl1340 N-Acetyl-gamma-glutamyl-phosphate reductase argC (C. glutamicum) argC 0.3 1.3 4.0
a Numbers for the corresponding ORFs of the revised C. glutamicum genome published by the National Center for Biotechnology Information (NCBI) (http://www
.ncbi.nlm.nih.gov/egi-bin/Eutrez/framikidbgenome&gi232). If no corresponding ORF exists, the position is given in parentheses.
b Most similar gene in public databases.
c Only characterized C. glutamicum genes are given.
d Average spot intensities of Coomassie-stained 2-D gels from cells cultivated without valine (Val) or in the presence of 300 mM L-valine (Val) and relative
protein abundances (with/without valine addition ratio). Only proteins with significant changes in abundance (P values of 0.1 in Student’s t test) are listed.
TABLE 5. Proteins showing altered abundances on 2-D gels in response to L-valine in the valine production strain VAL1a
ORF NCBI Annotation Gene
Intensityb
Val Val Ratio
1504 NCgl0899 Similarity to 2-nitropropane dioxygenase (Williopsis mrakii) 0.4 0.2 0.5
3194 NCgl2167 Pyruvate dehydrogenase component E1 aceE (C. glutamicum) 0.6 0.2 0.3
990 NCgl0478 Strong similarity to translation elongation factor EF-G fusA (E. coli) 0.3 0.6 2.3
1414 NCgl0827 Strong similarity to PurH bifunctional enzyme (E. coli) 0.3 1.5 4.3
2793 NCgl1222 Acetolactate synthase large-chain ilvB (C. glutamicum) ilvB 1.6 4.9 3.1
2793 NCgl1222 Acetolactate synthase large-chain ilvB (C. glutamicum) ilvB 0.8 3.1 3.6
2793 NCgl1222 Acetolactate synthase large-chain ilvB (C. glutamicum) ilvB 0.4 1.5 4.1
2793 NCgl1222 Acetolactate synthase large-chain ilvB (C. glutamicum) ilvB 0.2 0.7 4.2
2793 NCgl1222 Acetolactate synthase large-chain ilvB (C. glutamicum) ilvB 0.5 2.4 5.1
2793 NCgl1222 Acetolactate synthase large-chain ilvB (C. glutamicum) ilvB 0.6 3.4 5.3
2793 NCgl1222 Acetolactate synthase large-chain ilvB (C. glutamicum) ilvB 0.2 1.0 5.9
2793 NCgl1222 Acetolactate synthase large-chain ilvB (C. glutamicum) ilvB 0.2 1.6 7.2
a Abbreviations, conditions, and statistical analysis are described in footnotes to Table 3.
b Val, growth under addition of 40 mM L-valine.
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isoleucine had no effect on either growth or AHAS activity.
Thus, the presence of 40 mM isoleucine (instead of 3.4 mM,
always present as a supplement) was able to abolish the effects
of valine and leucine. In contrast to the VAL1 strain, the wild
type transformed with plasmid pJC1 showed doubling times of
1.6 to 2.1 h under all conditions mentioned above, slightly
increased AHAS activity upon isoleucine addition (120% of
the activity without isoleucine), and decreased activities in
response to all other conditions mentioned (40 to 70% of the
activity obtained without amino acid addition).
Correlation between valine inhibition and the ilvA deletion
of strain VAL1. The results described above clearly indicated
that the effects of valine and leucine on the growth and AHAS
activity of the VAL1 strain were caused by a limitation of
isoleucine, which is required by this strain as a supplement due
to the deletion of the ilvA gene encoding threonine dehy-
dratase. To confirm this conclusion, the effect of 200 mM
valine on the growth of a number of isogenic derivatives of the
wild type, ATCC 13032, was tested. As shown in Fig. 4, all six
strains investigated had the same doubling time (Td) of 1.7 h
in the absence of valine. In the presence of valine, there was a
slight increase in the doubling time due to the presence of
plasmid pJC1ilvBNCD (Td,2 h), but a large increase was due
to the ilvA deletion (Td, 2.7 h). The combination of plasmid
pJC1ilvBNCD and the ilvA deletion led to an even greater
increase of the doubling time (Td, 3.5 h), indicating that
these effects were synergistic. Strains carrying the plasmid
pJC1ilvBNCD produced more valine than the respective pJC1
control strains and thus were exposed to higher valine concen-
trations. The deletion of the panBC genes had no effect on
growth in the presence of valine. These data clearly support the
assumption that isoleucine limitation is responsible for growth
inhibition by valine and leucine in the VAL1 strain.
Abolishment of valine-triggered growth inhibition by sup-
plementation of the VAL1 strain with isoleucyl-isoleucine di-
peptide. From the sum of the results described above, the
conclusion was drawn that the isoleucine limitation in the pres-
ence of valine or leucine is caused by the competition of these
amino acids with isoleucine uptake by the carrier protein BrnQ
(15, 52). This carrier is responsible for the uptake of all three
branched-chain amino acids, and therefore, high concentra-
tions of valine or leucine compete for the uptake of the essen-
tial supplement isoleucine, which usually was present at an
initial concentration of 3.4 mM in the medium. Consequently,
the inhibitory effects of valine and leucine can be abolished by
increased isoleucine concentrations (Fig. 3). Final proof of this
explanation was obtained from an experiment in which the
dipeptide isoleucyl-isoleucine was used instead of isoleucine as
a supplement. In contrast to isoleucine, the dipeptide should
not be taken up by BrnQ but by a dipeptide transport system,
as in E. coli (12, 51), or by one of the peptide transport sys-
tems known from many other organisms (40). The putative
OppABCD ABC transport system induced by valine in VAL1
(Table 3) encodes a homologue of a peptide transport system
and thus could be induced because of the isoleucine limitation.
As expected, growth of the VAL1 strain in the presence of 1.7
mM isoleucyl-isoleucine was not inhibited by valine concentra-
tions of up to 200 mM, whereas the control supplemented with
3.4 mM isoleucine was strongly inhibited (Fig. 5).
As indicated in the introduction, the starting point of this
FIG. 3. Effects of L-valine, L-leucine, and L-isoleucine (40 mM
each) addition to the culture medium on doubling time (A) and spe-
cific AHAS activity (B) of C. glutamicum VAL1. The error bars indi-
cate standard deviations.
TABLE 6. AHAS activity after cultivation of wild-type
C. glutamicum ATCC 13032 and of the valine production






13032 0 20  15% 1
300 20 20% 1
VAL1 0 200 15% 10
40 700 25% 35
a AHAS activities are given with percent experimental imprecision.
b For relative AHAS activities, the activity in ATCC 13032 without valine
addition was normalized to 1.
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study was the inhibitory effect of valine on growth of the
leucine-auxotrophic lysine production strain C. glutamicum
MH20-22B (18). This effect could now also be explained by
competition of valine for leucine uptake via BrnQ. Growth
experiments confirmed that the inhibitory effect of valine was
abolished when leucine was provided in the form of the dipep-
tide alanyl-leucine instead of leucine (data not shown).
Influence of externally added valine on valine production by
the VAL1 strain. Since valine inhibited the growth and stimu-
lated the AHAS activity of the VAL1 strain supplemented with
isoleucine, it was interesting to examine the influence of exter-
nally added valine on valine production. The strain was culti-
vated three times independently with either 0, 40, or 175 mM
valine, and the valine concentration was determined after 24,
48, and 72 h. After 48 h, no further increase occurred. As
shown in Table 7, the initial addition of valine to the medium
had a positive effect on valine production, leading to an in-
crease of 33% (by addition of 40 mM valine) or even 50% (by
addition of 175 mM valine).
DISCUSSION
Based on the observation that L-valine inhibited the growth
of the lysine production strain C. glutamicum MH20-22B, the
effects of valine on the C. glutamicum wild type, ATCC 13032,
and a derived valine producer strain, VAL1, were studied in
this work. Remarkably, the growth of the wild type was not
influenced by valine, whereas growth of the VAL1 strain was
inhibited. Using a variety of techniques, such as transcript
profiling, proteome analysis, and enzymatic studies, we could
finally ascribe the inhibitory effect of valine on the isoleucine-
auxotrophic VAL1 strain to a competition of isoleucine with
valine for uptake by BrnQ. This secondary carrier is respon-
sible for the uptake of all branched-chain amino acids in C.
glutamicum (52) and has only slightly different affinities for
them (15). The isoleucine transport inhibition could be auto-
amplified by decreased BrnQ levels, since it has been reported
that brnQ is expressed only if the internal isoleucine concen-
tration exceeds 0.5 mM (5).
The first and most important hint of the occurrence of a
limitation of either isoleucine or leucine in the VAL1 strain
was obtained by transcriptome studies showing that the ilvBN
mRNA level was increased by valine in the VAL1 strain but
not in the wild type (the different levels of ilvB, ilvN, and ilvC
RNAs are caused by the fact that three different transcripts are
formed, i.e., the full-length ilvBNC transcript, an ilvNC tran-
script, and an ilvC transcript [28]). This is surprising, as valine
was previously shown to cause decreased ilvBNC transcription
due to an attenuation mechanism (38). The increased RNA
level correlated with an increased IlvB protein level (IlvN was
not present on the 2-D gels, which covered pH 4 to 7, due to
its predicted pI of 9.15 [http://www.expasy.org/tools/pi_tool
.html]) and an increased AHAS activity in the VAL1 strain.
Growth studies with all branched-chain amino acids used singly
or in combination then revealed that L-leucine had the same
FIG. 4. Doubling times of different strains derived from C. gluta-
micum ATCC 13032 without (shaded bars) or with (solid bars) addi-
tion of 200 mM L-valine. The strains utilized were ATCC 13032 (a),
13032panBC (b), 13032(pJC1ilvBNCD) (c), 13032ilvA (d), 13032ilvA
(pJC1ilvBNCD) (e), and VAL1 [13032 ilvA panBC(pJC1ilvBNCD)]
(f). Below the columns, it is indicated if the strains do () or do not
(wt) carry a deletion of ilvA or panBC and if the strains carry plasmid
pJC1ilvBNCD () or not ().
FIG. 5. Effects of different L-valine concentrations in the culture
medium on growth rates () of the C. glutamicum valine production
strain VAL1 when supplemented with 3.4 mM isoleucine () or 1.7
mM isoleucine dipeptide (E). The average growth rates and standard
deviations of two independent cultivations are given.
TABLE 7. Effects of different starting concentrations of L-valine
in the medium on L-valine production by VAL1a
Starting concn Final concn (48 h) Production
0  0 60  5 60  5
40  0 120 5 80  5
175  5 265 15 90  10
a Average values (millimolar L-valine) and standard deviations from three
independent parallel cultivations are given.
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effect as L-valine and that this effect could be abolished by
higher concentrations of L-isoleucine. Isoleucine, on the other
hand, had no effect on growth or AHAS activity. Thus, the
inhibitory effect was shown to be due to isoleucine limitation,
and this was confirmed by the fact that valine inhibition was
caused primarily by the ilvA deletion of the VAL1 strain. Final
proof of transport competition between valine and isoleucine
was obtained by a growth experiment using 1.7 mM isoleucyl-
isoleucine as a supplement instead of 3.4 mM isoleucine. This
dipeptide completely abolished valine-dependent growth inhi-
bition, because it is taken up by a peptide transport system
rather than by BrnQ and therefore valine does not compete
with its uptake.
Besides showing the differential effects of valine on ilvBN
expression in the wild type and the VAL1 strain, the transcrip-
tome studies identified totals of 39 and 21 ORFs that showed
at least twofold-changed mRNA levels in response to valine in
the wild type and the VAL1 strain, respectively. Three ORFs
showed similar increases of RNA levels in both strains, i.e., a
putative isoleucine-tRNA ligase gene (ileS), an adjacent short
hypothetical ORF (186 bp), and the leuD gene. In view of the
fact that isoleucine-tRNA ligase from E. coli is derepressed
under isoleucine starvation (23), the same could hold true in C.
glutamicum. Whereas isoleucine limitation in the VAL1 strain
has been unequivocally demonstrated and explained (see
above), its occurrence and the reason for its occurrence in the
wild type are not clear. One cause could be increased synthesis
of the branched-chain amino acid exporter BrnEF (29). Alter-
natively, a shortage of charged isoleucyl-tRNA could be caused
by a competition of valine and isoleucine for binding to iso-
leucyl-tRNA, as the isoleucyl-tRNA synthetase of E. coli also
misactivates valine (49). The leuD gene encodes one subunit of
isopropylmalate dehydratase, an enzyme involved in leucine
biosynthesis, and the increased leuD mRNA level in the pres-
ence of valine might indicate starvation for this amino acid,
similar to the case of ileS. The gene for the second subunit of
isopropylmalate dehydratase, leuC, showed 6.6- and 1.7-fold-
increased RNA levels in the wild type and the VAL1 strain,
respectively, but the P values were above 0.05. In the wild type,
leucine limitation again could be caused by an increased level
of the exporter BrnEF. In the VAL1 strain, however, the rea-
son for a possible leucine limitation is not obvious. Eventually,
valine could have a direct effect on leuCD expression in C.
glutamicum.
Interestingly, levels of RNAs of the prpD2B2C2 operon and
the prpC1 gene of the prpD1B1C1 operon were four- to sixfold
increased in the wild type but unchanged or even reduced in
the VAL1 strain. In the case of PrpD2, the increased RNA
level correlated with an eightfold-increased protein level on
2-D gels. The spots for PrpB2, PrpC2, and PrpC1 could not be
detected on the gels. The prpD2B2C2 operon is essential for
propionate utilization by C. glutamicum and is induced by
propionate (10). The operon shows sequence similarity to the
prp operons of Salmonella enterica serovar Typhimurium and
E. coli, in which it was shown that the encoded proteins convert
propionyl-CoA to pyruvate (26, 53). Since the degradation of
valine leads to the formation of propionyl-CoA (36, 60), the
induction of the prp genes by valine could indicate involvement
in the conversion of valine-derived propionyl-CoA to pyruvate.
However, we could show that C. glutamicum is unable to grow
with L-valine as a sole carbon source or as a sole nitrogen
source. Therefore, induction of the enzymes of the methylci-
trate cycle for the purpose of valine degradation does not make
sense. One could argue that the ability to catabolize valine was
lost fairly recently, whereas the regulatory mechanisms in-
volved remain unchanged. This appears to be unlikely, because
isoleucine, which, like valine, can be catabolized via propionyl-
CoA and therefore should also induce the prp genes, was found
to inhibit expression of the prpD2B2C2 operon (data not
shown). In conclusion, the reason for the induction of the prp
genes by valine (and their repression by isoleucine) remains
unclear. The same holds true for the result showing that valine
did not induce the prp genes in the VAL1 strain. The argument
that valine induction and isoleucine repression counterbalance
each other is unlikely because isoleucine was shown to be
limiting.
A comparison of the results of transcriptome and proteome
analyses revealed that 13 proteins had reduced levels in the
presence of valine, but none of the corresponding genes
showed decreased RNA levels. This might be explained by
some kind of technical limitation and/or by the fact that a
significant part of the regulation of protein synthesis does not
occur at the RNA level but by other means, e.g., translational
regulation or protein stability. In the cases of the proteins with
increased abundance in the presence of valine, most of the
corresponding genes (except those for PurH and EF-G) also
showed increased mRNA levels.
An important result of our studies was the observation that
the presence of valine in the medium stimulates its own pro-
duction by the VAL1 strain. This effect is presumably due to
the increased AHAS activity and to the growth inhibition,
which may favor valine production at the expense of biomass
formation. These aspects certainly should be considered in the
further improvement of VAL1 strain valine production by met-
abolic engineering.
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